Fulvestrant 250mg/5ml solution for injection pre-filled syringes
NHS hospitals in England used £19,957,892 of indicative cost of Fulvestrant 250mg/5ml solution for injection pre-filled syringes in the 12 months to July 2026, about 0.1% of all hospital medicines spend. That is up 2.3% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Fulvestrant 250mg/5ml solution for injection pre-filled syringes: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Fulvestrant 250mg/5ml solution for injection pre-filled syringes most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| The Christie Nhs Foundation Trust | £1,163,930 |
| The Royal Marsden Nhs Foundation Trust | £791,451 |
| The Clatterbridge Cancer Centre Nhs Ft | £685,924 |
| Univ Hpl B/Ham Nhs Foundation Trust | £626,892 |
| East And North Hertfordshire Nhs Trust | £414,794 |
| Nottingham University Hospitals Trust | £390,763 |
| Sheffield Teaching Hospitals Nhs Trust | £385,016 |
| Derby Teaching Hospitals Nhs Found Trust | £383,971 |
| Worcestershire Acute Hpls Nhs Trust | £358,373 |
| Portsmouth Hospitals Nhs Trust | £347,403 |
The primary-care picture
Fulvestrant is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Fulvestrant medicine page.